2021
DOI: 10.1007/s00380-021-01803-4
|View full text |Cite
|
Sign up to set email alerts
|

Clinical predictors and sequelae of computed tomography defined leaflet thrombosis following transcatheter aortic valve replacement at medium-term follow-up

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
3
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 10 publications
(3 citation statements)
references
References 42 publications
0
3
0
Order By: Relevance
“…The current analysis offers a detailed examination of potential predictors for HALT after TAVI in cardiac CT. In the literature, several clinical and procedural contributors to HALT after TAVI have been described, such as the absence of oral anticoagulation, the use of a large prosthesis, moderate-to-severe paravalvular leakage or balloon-expandable valves [ 26 29 ]. The current analysis extends the knowledge about potential predictors for HALT after TAVI.…”
Section: Discussionmentioning
confidence: 99%
“…The current analysis offers a detailed examination of potential predictors for HALT after TAVI in cardiac CT. In the literature, several clinical and procedural contributors to HALT after TAVI have been described, such as the absence of oral anticoagulation, the use of a large prosthesis, moderate-to-severe paravalvular leakage or balloon-expandable valves [ 26 29 ]. The current analysis extends the knowledge about potential predictors for HALT after TAVI.…”
Section: Discussionmentioning
confidence: 99%
“…This test can identify prosthesis thrombosis through morphological criteria with a finding of HALT that may be associated with HAM, and the possibility of assessing the thrombotic load, a parameter that has been correlated with adverse clinical outcomes. 4,9,10 HALT can be classified according to the extent of leaflet involvement as <25%, 25-50%, 50-75% or >75%, with this assessment being performed on CT diastolic reconstructions (Figure 6). However, the presence of HALT is observed at similar rates for transcatheter and surgical prosthetic valves.…”
Section: Discussionmentioning
confidence: 99%
“…11 Symptomatic thrombosis of aortic valve endoprosthesis leaflets is rare, representing about 0.6 to 2.8% of reported cases, 8 contrasting with incidental finding in about 15-40% of subclinical thrombosis with evidence of HALT on cardiac CT, with a potential association with cerebrovascular events. 5,7,9 Optimal antithrombotic therapy is still the focus of clinical trials, with current guidelines recommending dual antiplatelet therapy (DAPT) for three to six months after TAVI and data regarding safety and longevity suggesting good durability in five years. 1,7 However, some studies suggest that subclinical thrombosis is more common in those who did not receive anticoagulation, so that, after discontinuing DOAC, CT can reveal HALT in a variable degree, revealing its dynamic nature due to the potential of spontaneous progression or regression, even in asymptomatic patients.…”
Section: Discussionmentioning
confidence: 99%